BICO Group AB (publ) (OTCMKTS:CLLKF) Stock Price Up 35.3% – Still a Buy?

BICO Group AB (publ) (OTCMKTS:CLLKFGet Free Report) shot up 35.3% during trading on Wednesday . The stock traded as high as C$2.07 and last traded at C$2.07. Approximately 4,250 shares traded hands during mid-day trading, a decline of 51% from the average session volume of 8,624 shares. The stock had previously closed at C$1.53.

BICO Group AB (publ) Price Performance

The stock has a 50-day simple moving average of C$1.61 and a two-hundred day simple moving average of C$1.90.

About BICO Group AB (publ)

(Get Free Report)

BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.

In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.

Featured Articles

Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.